Tafoxiparin, a new drug candidate (phase II B) for cervical and uterine priming at planned delivery
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined